The Drugs Consultative Committee (DCC), a technical body of experts, had deliberated on the issue in its meeting last year after it received representation to amend the Drugs and Cosmetics Rules, 1945 with respect to concerns raised on the packing of eye drops in opaque plastic vials or bottles by pharmaceutical companies on the basis of historical testing results of eye drops sampling. The tests showed that most of the samples failed in the description due to particulate matter and contamination.
